|
WO2008070311A2
|
|
Gene expression profiling of parkinson's disease
|
|
WO2007084187A2
|
|
Molecular cardiotoxicology modeling
|
|
WO2007022419A2
|
|
Molecular toxicity models from isolated hepatocytes
|
|
WO2006037025A2
|
|
Molecular toxicity models from isolated hepatocytes
|
|
EP1751303A2
|
|
Hepatotoxicity molecular models
|
|
CA2546391A1
|
|
Methods for molecular toxicology modeling
|
|
US2007055448A1
|
|
Primary rat hepatocyte toxicity modeling
|
|
EP1641934A2
|
|
Methods for enhancing gene expression analysis
|
|
WO2005003370A2
|
|
Methods for enhancing gene expression analysis
|
|
US2004110193A1
|
|
Methods for classification of biological data
|
|
US2004048297A1
|
|
Nucleic acid detection assay control genes
|
|
US2004043405A1
|
|
Nucleic acid detection assay control genes
|
|
EP1578393A2
|
|
Primary rat hepatocyte toxicity modeling
|
|
AU2003214981A1
|
|
Molecular hepatotoxicology modeling
|
|
AU2002364077A8
|
|
Gene expression profiles in stomach cancer
|
|
US2007015146A1
|
|
Molecular nephrotoxicology modeling
|
|
AU2002350131A1
|
|
System and method for storage and analysis of gene expression data
|
|
AU2002327025A1
|
|
Identification of a cdna associated with ischemia in human heart tissue
|
|
WO03025135A2
|
|
Genes associated with malignant neoplasms
|
|
US7251642B1
|
|
Analysis engine and work space manager for use with gene expression data
|
